Watchlist Price Alert

Forma Therapeutics Inc. (FMTX)

NASDAQ: FMTX · Real-Time Price · USD

20.01

0.00 (0.00%)

At close: Oct 13, 2022, 8:00 PM

Forma Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.44M	10.82M	28.55M	100.56M	93.11M	89.74M	72.01M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	7.44M	10.82M	28.55M	100.56M	93.11M	89.74M	72.01M
Operating Income	-189.38M	-181.45M	-173.79M	-156.51M	-145.31M	-128.2M	-124.21M	-117.44M	-116.95M	-106.89M	-40.45M	-14.41M	17.34M	34.22M
Interest Income	1.39M	1.1M	1.07M	1.81M	2.46M	3.05M	3.43M	2.71M	2.41M	2.29M	2.85M	2.54M	1.98M	1.2M
Pretax Income	-190.13M	-181.01M	-172.81M	-154.49M	-142.63M	-127.83M	-100.13M	-93.64M	-93.2M	-80.61M	-36.64M	-11.35M	19.63M	35.71M
Net Income	-190.16M	-181.16M	-172.96M	-151.43M	-135.75M	-117.6M	-70.41M	-66.48M	-69.85M	-59.17M	-34.79M	-10.14M	20.85M	35.6M
Selling & General & Admin	53.06M	51.59M	48.33M	43.03M	37.74M	31.72M	30.78M	29.61M	29.18M	28.42M	24.4M	17.63M	10.61M	4.92M
Research & Development	138.06M	130.59M	125.66M	113.48M	107.58M	96.5M	93.37M	95.54M	98.32M	105.88M	111.31M	84.27M	56.72M	28.65M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	191.13M	182.19M	173.99M	156.51M	145.31M	128.22M	124.15M	125.16M	127.5M	134.29M	135.72M	101.9M	67.32M	33.57M
Interest Expense	888K	289K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	191.13M	182.19M	173.99M	156.51M	145.31M	128.22M	124.15M	125.16M	127.5M	134.29M	135.72M	101.9M	67.32M	33.57M
Income Tax Expense	28K	149K	154K	-3.07M	-6.88M	-10.23M	-29.72M	-27.16M	-22.59M	-20.68M	-1.08M	-451K	-1.22M	108K
Shares Outstanding (Basic)	47.81M	47.56M	47.39M	47.37M	47.34M	47.3M	42.24M	41.09M	5.94M	24.99M	24.99M	24.99M	24.99M	24.99M
Shares Outstanding (Diluted)	47.81M	47.56M	47.39M	47.37M	47.34M	47.3M	42.24M	41.09M	5.94M	27.04M	24.99M	27.04M	27.04M	27.04M
EPS (Basic)	-4	-3.82	-3.65	-3.27	-3.03	-6.39	-5.18	-5.49	-6.06	-2.37	-1.4	-0.41	0.83	1.42
EPS (Diluted)	-4	-3.82	-3.65	-3.27	-3.03	-6.39	-5.21	-5.52	-6	-2.27	-1.37	-0.38	0.77	1.32
EBITDA	-186.68M	-178.7M	-171.24M	-153.62M	-141.82M	-126.91M	-98.86M	-92.03M	-91.25M	-78.25M	-33.97M	-9.23M	21.17M	36.57M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	2.56M	2.02M	1.57M	872K	809K	916K	1.28M	1.62M	1.96M	2.36M	2.67M	2.13M	1.54M	855K